Vylor to Expand Soybean Leadership: Next-Gen Tech Platforms Maintain North America Yield Advantage, Accelerate Latin America Lineup via Broad Spectrum Insect Control

Corteva details Vylor’s multi-decade soybean tech roadmap, aiming for broader trait coverage, Latin American expansion and added revenue by 2035.

Rhea-AI Summary

Corteva (CTVA) outlined a long-term soybean growth strategy for its planned seed and genetics spin-off Vylor, targeting launch of four new technology platforms by 2035 and approximately $500 million in incremental revenue by 2035.

The company plans a next-generation proprietary platform for Latin America that couples elite germplasm with broad-spectrum insect control and herbicide tolerance, and expects Vylor’s combined launches to cover about 95% of its soybean business by the early 2030s. In North America, Vylor intends to build on its Enlist E3 franchise with next-generation herbicide tolerance platforms early next decade to protect and extend its yield-driven leadership. Vylor is also advancing a first-generation product targeting Asian Soybean Rust and a gene-edited, multi-disease resistance soybean, expected in the mid-2030s, supporting both proprietary brands and licensing-driven growth.

Positive

• Incremental revenue target of approximately $500 million by 2035 from new soybean technology platforms
• Planned technology launches expected to cover about 95% of Vylor’s soybean business by early 2030s

Negative

• None.

News Explained

The update remains a forward-looking operating plan rather than a completed separation: Corteva says Vylor’s separation is planned for October 1, 2026, while this release describes future soybean platforms and does not establish a completed ownership change for existing holders.

Market Context

1.62% was CTVA's pre-headline decline, while four of five supplied peers also traded lower. That bro...

Analysis

1.62% was CTVA's pre-headline decline, while four of five supplied peers also traded lower. That broader weakness provided market context for a forward-looking soybean-platform plan rather than a recorded post-announcement reaction.

Key Figures

Incremental revenue target: ~$500M Technology platforms: 4 Soybean business coverage: 95% +1 more

Incremental revenue target

~$500M

By 2035 from new soybean technology platforms

Technology platforms

4

Planned soybean platforms by 2035

Soybean business coverage

95%

Combined coverage from launches through the early 2030s

Planned separation date

October 1, 2026

Corteva and Vylor separation

Historical Context

1 past event · Latest: Sep 14

1 event

1. Sep 14

   Vylor distribution

   24h Move

   -1.6%

   Board approved pro rata Vylor distribution ahead of the planned October 1 separation.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

germplasm, herbicide tolerance, gene editing, broad spectrum insect control

4 terms

germplasm technical

"Combined with its continually improving, elite genetics"

Germplasm is the living genetic material—seeds, tissue, or cells—used to preserve and breed plants or animals. Think of it as a library or toolbox of traits (like drought tolerance or disease resistance) that breeders and biotech firms draw from to create new varieties. For investors, germplasm represents durable intellectual property and a source of future revenue and risk reduction because it underpins crop improvement, product differentiation, and resilience to changing markets and climates.

herbicide tolerance technical

"spanning insect and disease control as well as herbicide tolerance options"

A plant's ability to survive exposure to a specific weed-killing chemical without damage; often introduced by breeding or genetic modification so farmers can spray fields to kill weeds without harming the crop. Investors care because herbicide tolerance can change seed demand, input costs and regulatory risk for agricultural companies—like giving farmers a targeted tool that can boost yields but may also attract policy scrutiny or affect long-term weed control.

gene editing technical

"coupled with gene editing and trait solutions"

Gene editing is a set of laboratory techniques that change the DNA inside living cells to add, remove, or alter specific genes, like using precise 'cut-and-paste' tools to edit an instruction manual for a living organism. It matters to investors because successful edits can produce new therapies, improve agricultural products, or create commercial advantages; progress, safety, regulatory approvals, and patent control all affect a company’s value and risk profile.

broad spectrum insect control technical

"next-gen, proprietary broad spectrum insect control"

A pest-control product or technology that is effective against a wide range of insect species and often multiple life stages (eggs, larvae, adults). Like a multi-tool instead of a single screwdriver, it can replace several niche products and therefore matters to investors because it can broaden customer demand, simplify supply chains, and affect regulatory review and labeling requirements that influence sales and costs.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Launch of New Platforms to Outpace Industry and Deliver ~$500M Incremental Revenue by 2035

INDIANAPOLIS, Sept. 15, 2026 /PRNewswire/ -- Ahead of its planned separation on October 1, 2026, Corteva, Inc. (NYSE: CTVA) today announced plans to ramp up the soybean strategy of Vylor, it's advanced seed and genetics spin-off, launching four new technology platforms by 2035, including a proprietary, next generation technology platform for Latin America that will include the broadest spectrum of insect control on the market while also delivering strong yields for farmers and significant licensing opportunities for Vylor.

Vylor's launches through the end of the decade and into the early 2030s – spanning insect and disease control as well as herbicide tolerance options – will outpace every other player in the market; when combined, they will cover 95% of its soybean business. Combined with its continually improving, elite genetics, Vylor aims to leverage these technology platforms to deliver global soybean market leadership by the mid-2030s.

"Vylor has earned its market leadership in North America with its safe, effective technology, and today, we are laying the foundation to maintain and expand that leadership. We aim to leverage our market-leading Enlist E3® technology* with herbicide tolerance innovations that cement our leadership in North America and, through our elite germplasm and effective, broad-spectrum insect control package in Latin America and accelerate growth through licensing," said Judd O'Connor, chief commercial and operations officer for the future Vylor.

In North America, Vylor will expand beyond its proven Enlist E3 technology and launch its next generation herbicide tolerance platforms as soon as early next decade in its suite of products, offering farmers both elite germplasm and full protection of its superior yield potential. This suite of product offerings will allow Vylor to maintain and expand its soybean leadership across North America.

In Latin America, Vylor will continue its Conkesta® E3® momentum through the end of the decade, then pivoting to a new platform by coupling its elite germplasm with groundbreaking, next-gen, proprietary broad spectrum insect control and proven herbicide tolerance. The company expects its insect control package, which will include industry-leading yield performance, to become the preferred solution in the region. This technology is simpler to breed, making it faster and more efficient to deploy as compared to others, and will drive the company's market leadership in Latin America. 

Vylor is also advancing two industry firsts: a first-generation product to combat Asian Soybean Rust and protect yield potential and a gene edited, multi-disease resistance soybean. These technology platforms, expected in the mid-2030s, will complement the company's germplasm gains and broaden the role of soybean technology beyond herbicide and insect traits alone.

Overall, Vylor's soybean strategy comprises two pillars:

• Expand leadership by protecting the performance delivered by its elite germplasm coupled with gene editing and trait solutions on herbicide tolerance, disease and insect control; and
• Create a royalty-advantaged innovation engine that supports proprietary brands, licensing growth and sustained leadership.

Vylor's leadership in soybeans is built on its elite germplasm and the success of its Enlist E3 franchise, which helped the company achieve and maintain the #1 position in North America in soybeans.

Cautionary and Forward-Looking Statements

Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995: Corteva and its respective representatives may from time to time make written or oral statements that are "forward-looking" and provide other than historical information, including statements contained in this press release, in the company's other filings with the Securities and Exchange Commission ("SEC"), and in presentations, reports or letters to its stockholders.

In some cases, the company identified these forward-looking statements by such words or phrases as "plans," "outlook," "will," "is designed to," "is confident that," "expect," "expects," "should," "could," "may," "will continue to," "believe," "believes," "anticipates," "predicts," "forecasts," "estimates," "projects," "potential," "intends," or similar expressions identifying "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on the company's current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of Corteva's Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K"), the section captioned "Forward-Looking Information" in Part II of the 2025 Form 10-K, the "Risk Factors" and "Cautionary Statement Concerning Forward-Looking Statements" sections of the preliminary information statement filed as Exhibit 99.1 to Vylor Inc.'s ("Vylor") Registration Statement on Form 10, as amended, and to similar risk factors and cautionary statements in all other reports and forms filed with the SEC.

We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement. We specifically decline to undertake any obligation, and specifically disclaim any duty, to publicly update or revise any forward-looking statements that have been made to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events, except as may be required by law.

Examples of forward-looking statements include, but are not limited to, Corteva's intent to separate and its related expectations for Corteva and Vylor, including the anticipated timing, attributes, performance and financial, competitive and other benefits of these and any other products in Vylor's pipeline. These forward-looking statements reflect management's current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond Corteva's control.

About Vylor

Vylor is an advanced seed and genetics company that has, for more than a century, been focused on delivering groundbreaking innovation to farmers. Anchored in the agriculture industry's most elite germplasm and transformative biotech, Vylor leverages its scientific expertise to deliver next generation technology to help farmers around the world boost yields. With its expertise in advanced science, leading routes-to-market and an expanding licensing business, Vylor drives value and delivers growth for farmers, customers and shareholders – and in doing so, helps feed, fuel and clothe the world. More information at vylor.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/vylor-to-expand-soybean-leadership-next-gen-tech-platforms-maintain-north-america-yield-advantage-accelerate-latin-america-lineup-via-broad-spectrum-insect-control-302878275.html

SOURCE Corteva Agriscience